Vaxart, Inc. Total Long-Term Debt
Vaxart, Inc. (VXRT) had Total Long-Term Debt of $17.74 million as of 2018-12-31, per its 10-K filed 2019-02-06.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2019-02-06
- 2018-12-31: Long-term Debt $17.74M.
- 2018-09-30: Long-term Debt $17.58M.
- 2018-06-30: Long-term Debt $17.07M.
- 2018-03-30: Long-term Debt $16.60M.
| Period end | Long-term Debt | Long-term Debt as first filed |
|---|---|---|
| 2018-12-31 | $17.74M 10-K · filed 2019-02-06 | |
| 2018-09-30 | $17.58M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $17.07M 10-Q · filed 2018-08-10 | |
| 2018-03-30 | $16.60M 10-Q · filed 2018-05-15 | |
| 2018-02-12 | $16.30M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $15.90M 10-K · filed 2019-02-06 | $16.30M 10-Q · filed 2018-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |